Jaguar Health Files 8-K on Financials
Ticker: JAGX · Form: 8-K · Filed: 2026-04-07T08:35:22-04:00
Sentiment: neutral
Topics: financial-results, 8-k, sec-filing
Related Tickers: JAGX
TL;DR
Jaguar Health dropped an 8-K on 4/7/26 with financial updates. Check the filings for deets.
AI Summary
Jaguar Health, Inc. filed an 8-K on April 7, 2026, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with specific XBRL data available for detailed analysis. The company's mailing and business address is 200 Pine Street, Suite 400, San Francisco, CA 94104.
Why It Matters
This 8-K filing provides crucial updates on Jaguar Health's financial performance and condition, which is essential for investors and stakeholders to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — 8-K filings can contain significant financial or operational news, requiring careful review to understand potential risks or opportunities.
Key Players & Entities
- Jaguar Health, Inc. (company) — Filer of the 8-K
- 0001585608 (company) — CIK number for Jaguar Health, Inc.
- 2026-04-07 (date) — Filing date of the 8-K
- 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 (address) — Mailing and Business Address for Jaguar Health, Inc.
FAQ
What specific financial results are detailed in this 8-K filing?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes financial statements and exhibits, but the specific details of the results are not provided in the summary text.
When was this 8-K filing accepted by the SEC?
The 8-K filing was accepted by the SEC on 2026-04-07 at 08:35:22.
What are the CIK and EIN numbers for Jaguar Health, Inc. as listed in the filing?
The CIK number for Jaguar Health, Inc. is 0001585608, and the EIN is 000000000.
What is the business address of Jaguar Health, Inc.?
The business address of Jaguar Health, Inc. is 200 Pine Street, Suite 400, San Francisco, CA 94104.
Which items of Form 8-K are being reported on by Jaguar Health, Inc.?
Jaguar Health, Inc. is reporting on Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).
Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 10.6 · Accepted 2026-04-07 08:35:22
Key Financial Figures
- $0.0001 — ich registered Common Stock, Par Value $0.0001 Per Share JAGX The Nasdaq Stock Mar
Filing Documents
- d111491d8k.htm (8-K) — 25KB
- d111491dex991.htm (EX-99.1) — 51KB
- g111491g0407061029279.jpg (GRAPHIC) — 3KB
- 0001193125-26-144604.txt ( ) — 202KB
- jagx-20260407.xsd (EX-101.SCH) — 3KB
- jagx-20260407_lab.xml (EX-101.LAB) — 18KB
- jagx-20260407_pre.xml (EX-101.PRE) — 11KB
- d111491d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated April 7, 2026 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAGUAR HEALTH, INC. Date: April 7, 2026 By: /s/ Lisa A. Conte Lisa A. Conte Chief Executive Officer & President